Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 USD | +2.33% | -3.51% | -84.30% |
05-24 | Top Midday Decliners | MT |
05-24 | Genelux Prices $27.5 Million Securities Offering at $4 a Share; Shares Drop | MT |
Sales 2024 * | 6K 8.22K | Sales 2025 * | - | Capitalization | 75.57M 104M |
---|---|---|---|---|---|
Net income 2024 * | -27M -36.98M | Net income 2025 * | -35M -47.94M | EV / Sales 2024 * | 12,596 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.3
x | P/E ratio 2025 * |
-1.94
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.44% |
1 day | +2.33% | ||
1 week | -3.51% | ||
Current month | -18.82% | ||
1 month | -16.03% | ||
3 months | -63.46% | ||
6 months | -85.08% | ||
Current year | -84.30% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Zindrick
CEO | Chief Executive Officer | 65 | 09-12-31 |
Lourie Zak
DFI | Director of Finance/CFO | 61 | 23-08-27 |
Paul Scigalla
CTO | Chief Tech/Sci/R&D Officer | 79 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Tyree
BRD | Director/Board Member | 71 | 12-05-01 |
John Thomas
BRD | Director/Board Member | 66 | 02-08-31 |
John Smither
BRD | Director/Board Member | 71 | 23-09-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-27 | 2.2 | +2.33% | 136,088 |
24-06-26 | 2.15 | -4.87% | 180,297 |
24-06-25 | 2.26 | -0.88% | 190,395 |
24-06-24 | 2.28 | +10.68% | 149,266 |
24-06-21 | 2.06 | -9.65% | 223,319 |
Delayed Quote Nasdaq, June 27, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.30% | 75.57M | |
+16.13% | 122B | |
+19.65% | 113B | |
+19.51% | 26.49B | |
-23.84% | 19.4B | |
-18.19% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- GNLX Stock